Byron’s background is in psychology, which he studied to MSc level in 2006 before undertaking his PhD in 2009 at King’s College London in Prof Clive Ballard’s group. A major theme of Byron’s work in Prof Ballard’s group is understanding the genetic basis of neuropsychiatric symptoms in dementia and the overlap with other disorders across the lifespan. He has set up several international collaborations to work towards this aim. Byron moved to Exeter in November 2016 and, still working in Prof Ballard’s group, is now starting to extend his work into epigenetics by partnering with Prof Mill’s group.
Aside from genetics Byron is the project manager for the SMART-AD drug repurposing project, a member PROTECT study steering group (a major UK study examining factors influencing cognitive aging – www.protectstudy.org.uk) and he played a leading role in the management of the South London and Maudsley Care Home Research Network while at King’s (affiliated with the NIHR Biomedical Research Centre at King’s). Byron has also worked on several major industry and government funded clinical trials evaluating the effectiveness of various pharmacological and psychosocial interventions for neuropsychiatric symptoms in dementia.